Launch of PCR assay portfolio
02/02/2021
RNS
Total Voting Rights
01/02/2021
Full Year 2020 Trading Update
29/01/2021
Holding(s) in Company
26/01/2021
Holdings in Company
13/01/2021
Executive Management and Proposed Board Changes
05/01/2021
Liquidity Agreement and Total Voting Rights
04/01/2021
New COVID-19 variant
21/12/2020
Tests for new strains of COVID-19 and avian flu
14/12/2020
02/12/2020
01/12/2020
Director/PDMR Shareholding
18/11/2020
R&D Update
16/11/2020
13/11/2020
12/11/2020
11/11/2020
02/11/2020
Second Price Monitoring Extn
28/10/2020
Price Monitoring Extension
For Investor Relations Support for the Novacyt Group, please click the button below to contact our team.
